TheFiscalFinder
● Single award · contract

COVID-19: Sotrovimab Monoclonal Andtibodies

A single federal award, with both ends of the trail linked.
$1.6B
total award value
2021
action date
22 mo
period
W58P0522C0002
PIID
Agency ›
Department of Defense
✓ from source
awarded→$1.6B
Recipient ›
Glaxosmithkline, LLC
✓ from source
performed in→
State ›
North Carolina
✓ from source

Description

:COVID-19: Sotrovimab Monoclonal Andtibodies

Awarding agencyDepartment of Defense →
RecipientGlaxosmithkline, LLC →
Place of performanceNorth Carolina →
CategoryNAICS 325412PSC 6505
Competed?Not recorded✓ from source
Total (exact)$1,597,461,996

More awards to Glaxosmithkline, LLC

Vacines for Children
awarded 2017$682.2M
Glaxosmithkline Adjuvant AS03
awarded 2020$335.6M
All awards to this recipient →

More from Department of Defense

Contract HT940216C0001
awarded 2016$51.3B
LRIP Lot 12 Advance Acquisition Contract
awarded 2017$35.1B
SSN 802 and 803 Long Lead Time Material
awarded 2017$34.9B
Contract N0001902C3002
awarded 2001$34.2B
KC-X Modernization Program
awarded 2011$32B
All awards from this agency →
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.